Unveiling the Future of Chronic Insomnia treatment – DelveInsight's latest report explores epidemiological insights and market opportunities spanning the 7MM. LAS VEGAS , NV, UNITED STATES, January 31 ...
Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.
The Department of Health (DOH) on Friday warned that a certain page using the agency’s name to promote cure for insomnia is fake. In a Facebook advisory, the DOH said that ...
Managing insomnia: an overview of insomnia and pharmacologic treatment strategies in use and on the horizon ... doi:10.3390/nu8010053 Lewerenz J, Maher P. Chronic Glutamate Toxicity in ...
Jan. 24, 2025 — We're nearly one month into 2025, but if you're struggling to hold onto your New Year's resolution, stay strong, as new research shows that forming a healthy habit can take ...